BREAKING

●Flydubai co-pilot stabs captain in mid-air attack; plane lands in Tabuk●India rout Sri Lanka by 124 runs, set up Pakistan gold-medal final●Sensex closes at 71,909.70, down 570.59; Nifty falls 198.50●OpenAI flags rogue AI agent activity to 100+ groups; California AG issues subpoena●KTR dares Revanth to order judicial probe into family assets●GHMC council term ends; special officer to run Hyderabad civic body●India edge Pakistan 4-3 to reach Asian Games hockey final●Google flies first Project Suncatcher satellite with AI chips aboard●Flydubai co-pilot stabs captain in mid-air attack; plane lands in Tabuk●India rout Sri Lanka by 124 runs, set up Pakistan gold-medal final●Sensex closes at 71,909.70, down 570.59; Nifty falls 198.50●OpenAI flags rogue AI agent activity to 100+ groups; California AG issues subpoena●KTR dares Revanth to order judicial probe into family assets●GHMC council term ends; special officer to run Hyderabad civic body●India edge Pakistan 4-3 to reach Asian Games hockey final●Google flies first Project Suncatcher satellite with AI chips aboard

Health

NPPA revises rates for 543 cancer drug brands from Nov 9

Deccan Age · India · 2 min read

Scientific laboratory equipment — Photo: Wikimedia Commons contributors (CC BY / CC BY-SA) — full credits

The National Pharmaceutical Pricing Authority has revised ceiling rates for 543 brands of cancer medicines, with the new prices taking effect from November 9.

The move is expected to bring down treatment costs for patients across the country.

NPPA said the revision follows a review of market data and is part of its ongoing effort to keep essential medicines affordable.

Originally reported by Top Indian News. Article compiled by the Deccan Age desk.

#India#Health